WILL RUSSIAN QUALITY MARK BE RECOGNIZED AND IN DEMAND?

Nowadays the market is saturated with goods and services, people are always faced with the problem of selecting the best. The problem of choice became particularly acute when there was a separation of spheres of production. In the result, there was a need to delegate the right to choose an expert in this field. In the history of Russia, like in other countries, at the time of formation of a saturated market, there was a need to identify the manufacturer of high-quality goods and services. The easiest and most affordable way to identify honest manufacturers, whose products have passed the conformity assessment procedures, is the use of heraldic symbol in the goods description. The paper provides a brief history of quality marks in Russia. The article presents the rules developed by the non-profit organization "Roskachestvo" for the selection and evaluation of products, and the registration procedure of the right to use quality mark. The authors analyze factors promoting and impeding the introduction if the quality mark into the daily practice of marking the best domestic products

Revision Reconstruction of the Cervical Spine in a Patient With Early Deep Surgical Site Infection Complicated by Angular Kyphosis: Case Report and Review

Background. Deep surgical site infection (DSSI) is one of the most severe complications in spinal surgery. The timing and nature of DSSI are the determining criteria in the choice of treatment tactics. The uniqueness of the clinical observation is the combination of early DSSI, epidural abscess and angular kyphotic deformity formed after a course of conservative antibacterial therapy in a patient who underwent surgery for degenerative-dystrophic disease of the cervical spine. Correction of angular kyphosis, removal of fractured vertebrae, interbody implants and three-column cervical reconstruction were performed in one surgical session. Case presentation. A 57-year-old patient was admitted to the clinic after staged surgical interventions on the cervical spine for multilevel degenerative stenosis of the spinal canal. The primary surgical interventions were complicated by DSSI in the early period after the second surgery with formation of angular kyphosis of the cervical spine. The patient underwent revision one-stage reconstructive intervention to correct the deformity, decompress the spinal canal, and three-column reconstruction of C3-7 segments. Long-term follow-up showed persistent reduction of pain syndrome, improved quality of life and absence of recurrence of DSSI. Conclusion. The presented case illustrates the possibilities of one-stage revision three-column cervical spine reconstruction for correction of sagittal profile, decompression of intracanal neural structures and ensuring stability of operated segments. Use of DSSI treatment algorithms based on Prinz V. and Vajkoczy P. classification contributes to the selection of the optimal tactics of patient management

Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro

BACKGROUND: Tumour resistance to a wide range of drugs (multiple drug resistant, MDR) acquired after intensive chemotherapy is considered to be the main obstacle of the curative treatment of cancer patients. Recent work has shown that oncolytic viruses demonstrated prominent potential for effective treatment of diverse cancers. Here, we evaluated whether genetically modified vaccinia virus (LIVP-GFP) may be effective in treatment of cancers displaying MDR phenotype. METHODS: LIVP-GFP replication, transgene expression and cytopathic effects were analysed in human cervical carcinomas KB-3-1 (MDR−), KB-8-5 (MDR+) and in murine melanoma B-16 (MDR−), murine lymphosarcomas RLS and RLS-40 (MDR+). To investigate the efficacy of this therapy in vivo, we treated immunocompetent mice bearing murine lymphosarcoma RLS-40 (MDR+) (6- to 8-week-old female CBA mice; n = 10/group) or melanoma B-16 (MDR−) (6- to 8-week-old female C57Bl mice; n = 6/group) with LIVP-GFP (5 × 10(7) PFU of virus in 0.1 mL of IMDM immediately and 4 days after tumour implantation). RESULTS: We demonstrated that LIVP-GFP replication was effective in human cervical carcinomas KB-3-1 (MDR−) and KB-8-5 (MDR+) and in murine melanoma B-16 (MDR−), whereas active viral production was not detected in murine lymphosarcomas RLS and RLS-40 (MDR+). Additionally, it was found that in tumour models in immunocompetent mice under the optimized regimen intratumoural injections of LIVP-GFP significantly inhibited melanoma B16 (33 % of mice were with complete response after 90 days) and RLS-40 tumour growth (fourfold increase in tumour doubling time) as well as metastasis. CONCLUSION: The anti-tumour activity of LIVP-GFP is a result of direct oncolysis of tumour cells in case of melanoma B-16 because the virus effectively replicates and destroys these cells, and virus-mediated activation of the host immune system followed by immunologically mediated destruction of of tumour cells in case of lymphosarcoma RLS-40. Thus, the recombinant vaccinia virus LIVP-GFP is able to inhibit the growth of malignant cells with the MDR phenotype and tumour metastasis when administered in the early stages of tumour development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-1002-x) contains supplementary material, which is available to authorized users

INVESTIGATION OF CUTTING FORCE IN HARDENED STEEL TURNING

The paper presents results of the processing parameter effect, i.e. the magnitude of cutting speed and cutting force component feed in turning of hardened steel grades 45, 40X, 50X, CVH hardness 45..50 HRC with the help of the tool equipped with cutting ceramics EQA-60. The laboratory bench has been used for experimental studies, including a screw-cutting lathe 1K625 and the measuring device STD.201-2. The presence of the cutting speed range providing the minimum magnitude of the cutting force components is established

Synthesis of Magneto-Controllable Polymer Nanocarrier Based on Poly(N-isopropylacrylamide-co-acrylic Acid) for Doxorubicin Immobilization

In this work, the preparation procedure and properties of anionic magnetic microgels loaded with antitumor drug doxorubicin are described. The functional microgels were produced via the in situ formation of iron nanoparticles in an aqueous dispersion of polymer microgels based on poly(N-isopropylacrylamide-co-acrylic acid) (PNIPAM-PAA). The composition and morphology of the resulting composite microgels were studied by means of X-ray diffraction, Mössbauer spectroscopy, IR spectroscopy, scanning electron microscopy, atomic-force microscopy, laser microelectrophoresis, and static and dynamic light scattering. The forming nanoparticles were found to be β-FeO(OH). In physiological pH and ionic strength, the obtained composite microgels were shown to possess high colloid stability. The average size of the composites was 200 nm, while the zeta-potential was −27.5 mV. An optical tweezers study has demonstrated the possibility of manipulation with microgel using external magnetic fields. Loading of the composite microgel with doxorubicin did not lead to any change in particle size and colloidal stability. Magnetic-driven interaction of the drug-loaded microgel with model cell membranes was demonstrated by fluorescence microscopy. The described magnetic microgels demonstrate the potential for the controlled delivery of biologically active substances

Towards an Advanced Linear International Collider

This document provides detailed information on the status of Advanced and Novel Accelerators techniques and describes the steps that need to be envisaged for their implementation in future accelerators, in particular for high energy physics applications. It complements the overview prepared for the update of the European Strategy for particle physics, and provides a detailed description of the field. The scientific priorities of the community are described for each technique of acceleration able to achieve accelerating gradient in the GeV~range or above. ALEGRO working group leaders have coordinated the preparation of their working group contribution and contributed to editing the documents. The preparation of this document was coordinated by the Advanced LinEar collider study GROup, ALEGRO. The content was defined through discussions at the ALEGRO workshop in Oxford UK, March 2018, and an advanced draft was discussed during a one day meeting prior to the AAC workshop in Breckenridge, CO, USA, August 2018. This document was submitted as an addendum to the ALEGRO submission to the European Strategy for Particle Physics